Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

Clinical Trial
Study Details
Enrollment
40
Interventions
Description

Ammonia N 13 (a radioactive tracer) will be given per intravenous (IV) injection for diagnostic purposes in conjunction with positron emission tomography (PET) imaging.

Name
[13N]NH3
Type
Drug
Description

Given IV prior to PET stress test

Name
Lexiscan
Type
Drug
Description

Participants will complete a onetime PET (stress-rest) myocardial perfusion scan.

Name
Positron emission tomography
Type
Diagnostic Test
Phase
Phase 2
Status
RECRUITING
Study ID #
NCT05583721
Study Type
Interventional
Summary

There is limited information on what causes injury to the heart in individuals with Sickle Cell Disease (SCD). Researchers in this study want to see if decreased blood flow to the heart during stress could be causing the heart damage seen in SCD patients. They also want to test people who don't have SCD to see if their hearts react the same way under stress.

Primary Objective

* To estimate the coronary flow reserve (CFR) (also referred to as myocardial perfusion reserve), as measured by PET stress-rest myocardial perfusion imaging, in SCD patients with and without diastolic dysfunction, and healthy controls.

Secondary Objectives

* To investigate the relationship between decreased CFR (quantified with PET stress- rest myocardial perfusion imaging) and presence of abnormal diastolic parameters

Study Overview
Conditions
Description

This study requires two visits. The first visit includes blood tests, an electrocardiogram (EKG), and an echocardiogram. The second visit includes a positron emission tomography (PET) stress test and a blood test.

Subjects will be considered off-study one week after all post PET imaging study tests have been completed along with the next day and one-week follow-up phone calls are completed.

Contacts and Locations
Locations
Facility

St. Jude Children's Research Hospital
Memphis, Tennessee 38105
United States

GeoPoint
35.14953, -90.04898
Status
Recruiting